GUILFORD PHARMACEUTICALS INC Contracts & Agreements
29 Contracts & Agreements
- Business Finance (6 contracts)
- Human Resources (9)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (7)
- AGREEMENT AND PLAN OF MERGER DATED AS OF JULY 20, 2005 BY AND AMONG MGI PHARMA, INC., GRANITE ACQUISITION, INC. AND GUILFORD PHARMACEUTICALS, INC. (Filed With SEC on July 22, 2005)
- Amendment No. 2 to Rights Agreement (Filed With SEC on July 22, 2005)
- LINE OF CREDIT AGREEMENT (Filed With SEC on July 22, 2005)
- Sincerely, GUILFORD PHARMACEUTICALS INC. By: /s/ Dean J. Mitchell Name: Dean J. Mitchell Title: President and Chief ExecutiveOfficer PAUL ROYALTY FUND, L.P. By: Paul Capital... (Filed With SEC on July 22, 2005)
- THIS IS A RELEASE. YOU SHOULD READ IT CAREFULLY BEFORE YOU SIGN IT. SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on April 20, 2005)
- Tier Percentage of Base SalaryTier 1 25 % Tier 2 25 % Tier 3 15 % Tier 4 12.5 % Tier 5 10 % (Filed With SEC on April 11, 2005)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 7, 2005)
- FIRST AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on March 7, 2005)
- Second Amendment to the License Agreement (Filed With SEC on March 7, 2005)
- THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 7, 2005)
- AGREEMENT OF PURCHASE AND SALE (6411 Beckley Street & 6611 Tributary Street, Baltimore, Maryland) (Filed With SEC on December 22, 2004)
- AMENDED AND RESTATED SINGLE TENANT ABSOLUTE NET LEASE (Filed With SEC on December 22, 2004)
- AMENDED AND RESTATED SINGLE TENANT ABSOLUTE NET LEASE (Filed With SEC on December 22, 2004)
- GUILFORD PHARMACEUTICALS INC. 2002 STOCK AWARD AND INCENTIVE PLAN DIRECTOR STOCK UNIT AGREEMENT (Filed With SEC on November 9, 2004)
- GUILFORD PHARMACEUTICALS INC. COMPENSATION PLAN FOR OUTSIDE DIRECTORS (Filed With SEC on October 5, 2004)
- CONSULTING SERVICES AND SEPARATION AGREEMENT (Filed With SEC on September 3, 2004)
- MANUFACTURING AND SUPPLY AGREEMENT By and Between GUILFORD PHARMACEUTICALS INC. and BAXTER HEALTHCARE CORPORATION *The asterisk denotes that confidential portions of this exhibit... (Filed With SEC on August 9, 2004)
- GUILFORD PHARMACEUTICALS INC. 10,000,000 Shares Common Stock ($0.01 par value per Share) Underwriting Agreement (Filed With SEC on July 1, 2004)
- AMENDMENT NO. 2 TO CONSULTING AGREEMENT (Filed With SEC on May 10, 2004)
- INDENTURE between Guilford Pharmaceuticals Inc. and Wachovia Bank, National Association as Trustee $60,000,000 5% Convertible Subordinated Notes due 2008* Dated as of June 17, 2003 (Filed With SEC on August 7, 2003)
- Guilford Pharmaceuticals Inc. $60,000,000 5% Convertible Subordinated Notes Due 2008 REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 7, 2003)
- GUILFORD PHARMACEUTICALS INC. 2002 STOCK AWARD AND INCENTIVE PLAN (Filed With SEC on March 31, 2003)
- FORM OF SEVERANCE AGREEMENT (Filed With SEC on March 31, 2003)
- EX-10.63 Employment Letter Agreement (Filed With SEC on March 30, 2001)
- EX-10.64 Employment Letter Agreement (Filed With SEC on March 30, 2001)
- EXHIBIT 1.1 Guilford Pharmaceuticals Inc. 6611 Tributary Street Baltimore, Maryland 21224 (Filed With SEC on January 17, 2001)
- EXHIBIT 1.2 (Filed With SEC on January 17, 2001)
- EXHIBIT 1.1 January 5, 2001 (Filed With SEC on January 8, 2001)
- EXHIBIT 1.1 Guilford Pharmaceuticals Inc. 611 Tributary Street Baltimore, Maryland 21224 (Filed With SEC on December 15, 2000)
